Education
About Us
Working with TipRanks
Follow Us
Infinity Pharmaceuticals (INFIQ)
OTHER OTC:INFIQ
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 2.59M | $ 1.86M | $ 1.72M | $ 3.05M |
| Gross Profit | $ 1.03M | $ 738.00K | $ 682.00K | $ -4.26M |
| Operating Income | $ -44.84M | $ -45.08M | $ -38.50M | $ -45.66M |
| EBITDA | $ -43.73M | $ -44.60M | $ -37.56M | $ -44.33M |
| Net Income | $ -44.37M | $ -45.26M | $ -40.49M | $ -47.06M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 38.31M | $ 80.73M | $ 34.11M | $ 42.44M |
| Total Assets | $ 42.15M | $ 84.78M | $ 39.32M | $ 49.01M |
| Total Debt | $ 48.13M | $ 51.06M | $ 24.33M | $ 31.93M |
| Net Debt | $ 9.82M | $ -79.29M | $ -4.26M | $ 9.67M |
| Total Liabilities | $ 61.20M | $ 63.21M | $ 62.31M | $ 41.29M |
| Stockholders' Equity | $ -19.05M | $ 21.57M | $ -22.99M | $ 7.73M |
| Cash Flow | ||||
| Free Cash Flow | $ -42.45M | $ -40.63M | $ -35.78M | $ -43.86M |
| Operating Cash Flow | $ -42.43M | $ -40.62M | $ -35.74M | $ -41.53M |
| Investing Cash Flow | $ -55.00K | $ 5.49M | $ 14.63M | $ -12.24M |
| Financing Cash Flow | $ 73.00K | $ 87.11M | $ 27.44M | $ 27.73M |
Infinity Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.